Status:
COMPLETED
Comparasion of Efficacy of Nebulized With Intravenous Magnesium Sulphate in Children With Asthma
Lead Sponsor:
Saima Khatoon
Collaborating Sponsors:
King Edward Medical University
Conditions:
Asthma in Children
Eligibility:
All Genders
2-12 years
Phase:
PHASE4
Brief Summary
The purpose of study is to assess the effectiveness of nebulized magnesium sulphate in children presenting with acute asthma.Study perfoma consists of demographic variables,exclusion criteria and pedi...
Detailed Description
After getting informed consent from guardian,148 patients of acute moderate ro severe asthma with pediatric asthma score 8-15 will be randomly classified into 2 groups and one group will receive nebul...
Eligibility Criteria
Inclusion
- patients with age 2 to 12 years with acute moderate to severe exacerbation of asthma as per operational definition children who are unrespoinsive to standard treatment of asthma at 60 minutes
Exclusion
- those with history of chronic lung disease and abnormal renal function contraindication for MgSO4 due to hepatic or renal disease allergy to MgSo4 children who has other comorbid illness
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT04497766
Start Date
October 1 2019
End Date
September 30 2020
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King edward medical university/mayo hospital lahore
Lahore, Punjab Province, Pakistan, 56000